Table 10 CSS analysis for patients with rectal cancer
Characteristics | Â | RMSTb (95%CI) | HRc (95%CI) | P valuea | Interaction p | |
|---|---|---|---|---|---|---|
Non-chemotherapy | Chemotherapy | |||||
Total | – | 53.8 (51.7–55.3) | 56.2 (50.1–57.1) | 0.586 (0.311–1.105) | 0.094 | – |
Sex | Male | 53.2 (50.7–55.3) | 55.9 (54.4–57.1) | 0.515 (0.251–1.056) | 0.065 | 0.488 |
Female | 54.5 (51.3–56.5) | 56.8 (55.0–58.0) | 0.989 (0.245–3.983) | 0.987 |  | |
Age (years) | ≤55 | 54.3 (47.9–57.4) | 56.3 (54.2–57.7) | 0.965 (0.205–4.548) | 0.964 | 0.630 |
56–60 | 55.4 (47.4–58.5) | 56.8 (54.2–58.3) | 0.463 (0.085–2.527) | 0.362 |  | |
61–65 | 53.3 (46.5–57.0) | 55.7 (52.8–57.4) | 0.466 (0.109–1.985) | 0.290 |  | |
66–70 | 53.2 (48.2–56.3) | 57.3 (53.7–58.8) | 0.329 (0.046–2.369) | 0.246 |  | |
> 70 | 53.6 (50.6–55.8) | 54.6 (50.0–57.2) | 0.833 (0.221–3.143) | 0.787 |  | |
Size (cm) | ≤5.0 | 54.0 (51.3–55.9) | 56.1 (54.6–57.2) | 0.575 (0.261–1.269) | 0.165 | 0.342 |
> 5.0 | 53.7 (50.4–55.8) | 56.3 (54.4–57.5) | 0.711 (0.232–2.177) | 0.549 |  | |
Differentiation | Well-moderate | 53.9 (51.9–55.4) | 56.3 (55.1–57.2) | 0.608 (0.313–1.180) | 0.137 | 0.900 |
Poor | 52.0 (43.1–56.2) | 54.7 (47.5–58.1) | 0.372 (0.033–4.146) | 0.403 |  | |
T category | 3 | 56.4 (54.1–58.0) | 57.6 (55.4–58.7) | 0.792 (0.255–2.456) | 0.685 | 0.376 |
4 | 51.8 (48.7–54.0) | 55.6 (54.2–56.7) | 0.465 (0.215–1.003) | 0.046 |  | |
CEAd (ng/mL) | < 5 | 54.6 (51.9–56.6) | 56.8 (55.3–57.8) | 0.792 (0.312–2.013) | 0.624 | 0.681 |
≥5 | 53.5 (50.2–55.7) | 55.1 (52.6–56.8) | 0.457 (0.153–1.366) | 0.151 |  | |
Examined lymph nodes | < 12 | 52.0 (47.8–54.9) | 53.6 (50.4–55.7) | 0.950 (0.324–2.786) | 0.926 | 0.249 |
≥12 | 54.4 (52.2–56.1) | 57.1 (55.9–57.9) | 0.444 (0.199–0.990) | 0.041 |  | |
PLRe | ≤130 | 56.0 (53.7–57.6) | 56.0 (54.4–57.1) | 0.833 (0.352–1.967) | 0.676 | 0.202 |
> 130 | 51.3 (48.2–53.8) | 56.5 (54.9–57.8) | 0.360 (0.134–0.969) | 0.035 |  | |